Name
Aktsiaselts Medical Pharmacy Group
Registry code
12356191
VAT number
EE101743570
Type
AS - Joint Stock Company
Status
Bankrupt
Foundation date
04.10.2012 (12)
Financial year
01.01-31.12
Capital
518 986.00 €
Activity
47911 - Retail sale via mail order houses or via Internet 9609 - Other personal service activities n.e.c. 21201 - Manufacture of pharmaceutical preparations
-
-
-
-
-
-
Not submitted
70 414 €
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Worldlife Estonia OÜ 12178803 | 63% - 328 404.40 EUR | - | - | FounderShareholder |
| Jüri Truuts 24.01.1970 (54) | - | Bankruptcy trustee | - | |
| Swen Uusjärv 08.05.1977 (47) | - | - | Indirect ownership | Chairman of the board |
| Rein Muoni 21.01.1948 (76) | - | - | - | Board member |
| Tarmo Oras 01.07.1975 (49) | - | - | - | Board member |
| Toomas Kaevand 22.04.1978 (46) | - | - | - | Board member |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| MTÜ Personalised Medicine Association 80561497 | - | - | - | Founder (without contribution) |
| 2019 04.10.2021 | 2020 18.11.2021 | |
|---|---|---|
| Total Revenue | 338 386 € | 429 050 € |
| Net profit (loss) for the period | -987 099 € | -645 803 € |
| Profit Margin | -292% | -151% |
| Current Assets | 513 990 € | 256 032 € |
| Fixed Assets | 519 372 € | 450 243 € |
| Total Assets | 1 033 362 € | 706 275 € |
| Current Liabilities | 535 115 € | 1 898 477 € |
| Non Current Liabilities | 1 223 900 € | 149 255 € |
| Total Liabilities | 1 759 015 € | 2 047 732 € |
| Share Capital | 518 104 € | 518 545 € |
| Equity | -725 653 € | -1 341 457 € |
| Employees | 33 | 15 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 9 050.07 € | 4 577.07 € | 8 |
| 2023 Q4 | 34 921.66 € | 7 255.53 € | 6 713.75 € | 7 |
| 2023 Q3 | 40 115.64 € | 24 598.04 € | 17 478.72 € | 7 |
| 2023 Q2 | 40 547.98 € | 805.75 € | 607.44 € | 7 |
| 2023 Q1 | 46 373.22 € | 17 326.59 € | 10 247.84 € | 9 |
| 2022 Q4 | 66 174.16 € | 34 189.83 € | 27 382.35 € | 10 |
| 2022 Q3 | 40 182.58 € | - | - | 9 |
| 2022 Q2 | - | - | - | 8 |
| 2022 Q1 | - | 10 714.73 € | 7 723.83 € | 8 |
| 2021 Q4 | 20 007.72 € | 22 686.06 € | 14 381.14 € | 8 |
| 2021 Q3 | 55 101.65 € | 48 032.84 € | 38 207.19 € | 9 |
| 2021 Q2 | 104 521.89 € | 19 228.09 € | 19 650.07 € | 13 |
| 2021 Q1 | 81 826.75 € | 11 601.5 € | 9 318.36 € | 15 |
| 2020 Q4 | 148 264.98 € | 37 430.33 € | 34 142.12 € | 13 |
| 2020 Q3 | 105 039.66 € | 4 485 € | 5 010.42 € | 14 |
| 2020 Q2 | 131 998.89 € | 9 477.3 € | 9 477.3 € | 18 |
| 2020 Q1 | 108 380.99 € | 45 228.28 € | 49 543.34 € | 28 |
